Trial Profile
Adherence to regorafenib therapy in patients with previously treated metastatic colorectal cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Jul 2015
Price :
$35
*
At a glance
- Drugs Regorafenib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 03 Jul 2015 New trial record
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.